Qlaris Bio

Dedham, MA · Founded 2019 · Privately Held (backing)

Developer of novel therapies designed to treat serious and debilitating ophthalmic diseases. Qlaris Bio is based in Dedham, MA and was founded in 2019. Its last reported valuation was $68 million in Apr 2024. It has raised $55 million across 4 recorded rounds; the latest was a $3.9 million seed round in Jun 2026.

Last reported valuation
$68.0M
Oct 2026
Priced at
—
Total raised
$55.0M
Last round
Seed Round
Jun 2026

Who backs Qlaris Bio?

6 investors
InvestorType
Correlation VenturesVenture capital
Canaan PartnersVenture capital
Mayo ClinicOther
Mayo Clinic Ventures—
New Leaf VentureVenture capital
Aberdeen Investments (Scotland)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Qlaris Bio investors

6 investors are on record for Qlaris Bio, including Correlation Ventures, Canaan Partners, Mayo Clinic and Mayo Clinic Ventures. The seed round in Jun 2026 drew 8 investors.

Free account
More of Qlaris Bio with a free account
  • ·Watch Qlaris Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Qlaris Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View